Stock Market News 19 hours agoShould You Buy Before the Ex-Dividend Date or Wait? Whether you're a newcomer to the world of dividend stocks or a veteran, the question of whether to buy before the ex-dividend date will always be one to ponder. Buying a dividend stock before the ex-dividend date seems evident since you would be entitled to receive the dividend. However, if you understand what happens when a dividend is distributed, the answer gets more involved. New dividend investors mistakenly believe that a dividend is a free money for shareholders. It's a way of getting income from holding dividend stocks. That…Read Article 19 hours agoDividends, Short-Term Pain, but Long-Term Gain? Dividend stocks drop by the dividend amount on the ex-dividend date. The stock takes a short-term hit, but the shareholders are compensated in cash on the payout date. If it's a wash, why are there so many dividend investors? Simple. Dividend investors seek income from holding their stocks long-term. They don't feel they lose anything because they are getting paid the dividend, and the short-term price drop will eventually be recovered if they hold the stock long enough. Well, that may only sometimes be the case. Benchmark Indexes Rise…Read Article 15 hours agoCan Carnival Cruise Lines Set Sail For New Highs? Carnival Cruise Lines (NYSE: CCL) has been weathering stormy seas for the last 2 years, but the skies are clearing, and smoother sailing is ahead. The headwinds are not over, but signs within the Q1 earnings report point to a return to normalcy that includes positive cash flow and debt reduction. What this means for investors is a chance to buy this stock at the lowest prices it has seen in 20 years and at an 80% discount to its prepandemic price point. The Bad Times Are Behind Carnival Cruise Lines The signal in the results…Read Article 17 hours agoBioNTech Is Ripe For A Rebound In 2023 BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a substantial correction since then due to slowing COVID sales, but the bottom is in. While COVID sales have slowed, this company is not dependent on COVID for its bread and butter and is set up for a rebound in 2023. Not only does it have a growing pipeline of drugs and candidates in the pipeline advancing toward approval, but there are factors in play that make it a potential takeover target…Read Article 13 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) finished with a gain of 9.68%, following promising news about the companies’ jointly developed medication Dupixent. In Phase 3 clinical trials, Dupixent reduced severe flare-ups of chronic obstructive pulmonary disease (COPD) at a far better rate than a placebo. In a joint news release, the companies said, “Dupixent is the first and only biologic to demonstrate a clinically meaningful and highly…Read Article Latest Stock Market News 20 minutes agoAsian shares mostly rise on relief over US bank strength8 hours agoFed official: SVB itself was main cause of bank's failure10 hours agoHow major US stock indexes fared Monday 3/27/202311 hours agoSouth Dakota gov's veto of cryptocurrency regulations upheld12 hours ago3 High Yields On Breakout Watch With Analyst Tailwinds13 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment14 hours agoCollapsed Silicon Valley Bank Finds a Buyer15 hours ago3 Financials The Insiders Are Buying 15 hours agoReport: Elon Musk Says Twitter Is Valued At Less Than Half of What He Paid For It Just Days After Sending Frantic Email to Employees at 2:30 A.M.15 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 15 hours agoCold Stone Creamery Employees Quit En Masse After Fellow Worker Loses 3 Fingers on the Job15 hours agoDeath Tolls Rises Following Chocolate Factory Explosion Free Email Newsletter Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter: Your Email Address Sector Performance Ad Vector VestFree Stock Analysis Report: See The True Value of Any StockGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free Popular Articles1+ days ago | March 22nd | 2023 7:00AM3 Dividend Contenders to Buy Now for Long-Term Gains Later1+ days agoWhy Wall Street Loves These 3 Penny Stocks1+ days ago3 Tech Stocks Well Positioned For Growth At A Reasonable Price 1+ days ago5 Best Dividend Capture Stocks 1+ days agoDividend King Genuine Parts Company Upgraded On Profit GuidanceStock Ideas12 hours ago | March 27th | 2023 2:30PM3 High Yields On Breakout Watch With Analyst Tailwinds13 hours agoSanofi, Regeneron Shares Pop On Big News About COPD Treatment15 hours agoCan Carnival Cruise Lines Set Sail For New Highs? 17 hours agoIf Safety is Your Concern, Then Take a Look at Sandy Spring Bank17 hours agoBioNTech Is Ripe For A Rebound In 2023 Instant Alerts13 minutes ago | March 28th | 2023 2:48AMHealthpeak Properties, Inc. (NYSE:PEAK) Given Average Recommendation of "Hold" by Analysts13 minutes agoWynn Resorts, Limited (NASDAQ:WYNN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages13 minutes agoDelek US Holdings, Inc. (NYSE:DK) Given Consensus Recommendation of "Hold" by Brokerages13 minutes agoEOG Resources, Inc. (NYSE:EOG) Receives Average Recommendation of "Moderate Buy" from Analysts13 minutes agoAutodesk, Inc. (NASDAQ:ADSK) Receives Consensus Recommendation of "Moderate Buy" from Analysts13 minutes agoVisa Inc. (NYSE:V) Receives Average Recommendation of "Moderate Buy" from Brokerages Ad Vector VestFree Stock Analysis Report: See The True Value of Any StockGet a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. Analyze Any Stock Free Popular StocksCompanyCurrent PricePrice ChangeAAPLApple Inc.$158.28-1.23%MSFTMicrosoft Co.$276.38-1.49%METAMeta Platforms, Inc.$202.84-1.54%GOOGLAlphabet Inc.$102.46-2.83%AMZNAmazon.com, Inc.$98.04-0.09%TSLATesla, Inc.$191.810.74%NVDANVIDIA Co.$265.31-0.93%NIONio Inc -$8.93-1.54%BABAAlibaba Group Holding Limited$86.12-0.90%AMDAdvanced Micro Devices, Inc.$96.61-1.37%TAT&T Inc.$18.871.40%FFord Motor$11.520.09%MUMicron Technology, Inc.$59.79-2.24%Follow Stocks Analyst RatingsCompanyBrokerageActionSLGSL Green Realty Corp.CitigroupLower Price Target$35.00 ➝ $17.00JOANJOANN Inc.Bank of AmericaLower Price Target$3.50 ➝ $1.00BNTXBioNTech SEBank of AmericaLower Price Target$239.00 ➝ $194.00FOLDAmicus Therapeutics, Inc.Bank of AmericaBoost Price Target$16.00 ➝ $17.00LULULululemon Athletica Inc.BarclaysLower Price Target$394.00 ➝ $368.00PSNParsons Co.William BlairUpgradeto OutperformGMDAGamida Cell Ltd.OppenheimerLower Price Target$10.00 ➝ $8.00GERNGeron Co.The Goldman Sachs GroupInitiated Coverageat NeutralRGENRepligen Co.BenchmarkInitiated Coverageat BuyBOWLBowlero Corp.Stifel NicolausInitiated Coverageat BuyCARRCarrier Global Co.OppenheimerInitiated Coverageat OutperformLIILennox International Inc.OppenheimerInitiated Coverageat Market PerformSee All Analyst Ratings Today's Top GainersCompanyPrice ChangeIndicatorEVCIEVCI Career Colleges Holding Corp.146.15%News CoverageGap UpINNVDInnovus Pharmaceuticals Inc143.90%Gap UpEJMLLFantex, Inc.100.00%Gap UpWISAWiSA Technologies, Inc.89.47%Short Interest ↓High Trading VolumeCERPQCereplast, Inc.64.65%Gap DownHigh Trading VolumeCUENWCuentas Inc.60.00%Positive NewsGap DownHigh Trading VolumeUMLGFUnited Malt Group Limited57.20%News CoverageGap UpCCTCClean Coal Technologies, Inc.53.85%Short Interest ↓Gap UpHigh Trading VolumeFCNCAFirst Citizens BancShares, Inc.53.74%Short Interest ↓News CoveragePositive NewsGap UpHigh Trading VolumeSRAXSRAX, Inc.46.34%Gap UpLMAOULMF Acquisition Opportunities, Inc.41.59%Gap UpHigh Trading VolumeGRRRGorilla Technology Group Inc.41.15%News CoverageGap UpHigh Trading VolumeSee More Top Gainers Today's Top LosersCompanyPrice ChangeIndicatorESRCFESR Group Limited-84.03%Gap DownMMTLPMeta Materials Inc.-58.64%Gap DownHigh Trading VolumeCDAKCodiak BioSciences, Inc.-56.75%Upcoming EarningsShort Interest ↑News CoverageGap DownHigh Trading VolumeUBXUnity Biotechnology, Inc.-53.01%News CoverageGap DownHigh Trading VolumeGMDAGamida Cell Ltd.-49.63%Analyst ReportShort Interest ↓News CoverageGap DownHigh Trading VolumeHCYTDH-CYTE, Inc.-49.50%Gap DownHigh Trading VolumeVRSRFVersarien plc-48.48%Gap DownTNLXTrans-Lux Co.-43.32%Gap DownZURAZura Bio Limited-42.76%Gap UpHigh Trading VolumeJATTJATT Acquisition Corp-42.76%Gap UpHigh Trading VolumeLTONYMNC Media Investment Ltd -42.19%Gap DownHigh Trading VolumeSONNSonnet BioTherapeutics Holdings, Inc.-41.04%Short Interest ↓Positive NewsGap DownHigh Trading VolumeSee More Top Losers × Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.